← Back to Search

SPIRIT-Dementia for Kidney Failure

N/A
Waitlist Available
Led By Mi-Kyung Song, RN, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
receiving in-center hemodialysis
diagnosed with dementia or having mild to moderate cognitive impairment based on a Montreal Cognitive Assessment (MoCA) score 13-25 or a Saint Louis University Mental Status (SLUMS) score < 27 (high school education) or < 25 (less than high school education)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months post-intervention
Awards & highlights

Study Summary

This trial will test whether the SPIRIT-dementia intervention improves preparedness outcomes for caregivers of patients with dementia.

Eligible Conditions
  • Kidney Failure

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You can understand and speak English.\n

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dyad Congruence
Patient's Decisional Conflict Scale (DCS) Score
Surrogate's Decision Making Confidence (DMC) Scale Score
Secondary outcome measures
Care Decisions (Withdrawal From Dialysis, DNR, Hospice Enrollment)
Surrogate's Anxiety-Score Using the Hospital Anxiety and Depression Scale (HADS) Score
Surrogate's Depression-Score by Using the Hospital Anxiety and Depression Scale (HADS) Score

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SPIRIT-DementiaExperimental Treatment1 Intervention
Patients and their surrogates randomized to this study arm will receive the SPIRIT-dementia intervention.
Group II: Usual CareActive Control1 Intervention
Patients and surrogates randomized to this study arm will receive the standard information about advance directives that is provided at the time of diagnosis.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SPIRIT-Dementia
2020
N/A
~40

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,535 Total Patients Enrolled
3 Trials studying Kidney Failure
1,551 Patients Enrolled for Kidney Failure
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,005,076 Total Patients Enrolled
National Institute of Nursing Research (NINR)NIH
579 Previous Clinical Trials
10,376,344 Total Patients Enrolled
2 Trials studying Kidney Failure
2,145 Patients Enrolled for Kidney Failure

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being accepted for this experiment currently?

"Clinicaltrials.gov reveals that recruitment for this trial has already ceased, as the last edit was made on April 28th 2022. Although no longer enrolling patients, there are presently 572 other trials searching for participants."

Answered by AI

Who else is applying?

What state do they live in?
Georgia
How old are they?
18 - 65
What site did they apply to?
Emory Dialysis at Candler
What portion of applicants met pre-screening criteria?
Met criteria
~7 spots leftby Apr 2025